AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAD8. A total of 21 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $7,182,000 | +14.9% | 8,000,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $6,253,000 | +1.5% | 8,000,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $6,162,000 | -8.5% | 8,000,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $6,731,000 | +66.9% | 8,000,000 | +70.2% | 0.00% | +50.0% |
| Q4 2017 | $4,033,000 | – | 4,700,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birch Grove Capital LP | 25,985,000 | $23,462,000 | 12.71% |
| ANGELO GORDON & CO., L.P. | 39,070,000 | $38,738,000 | 4.35% |
| Context Partners Fund, L.P. | 14,068,000 | $12,630,000 | 2.74% |
| Context Capital Management, LLC | 14,068,000 | $12,630,000 | 2.74% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 48,555,000 | $43,700,000 | 2.36% |
| UBS OCONNOR LLC | 41,000,000 | $36,888,000,000 | 0.94% |
| WHITEBOX ADVISORS LLC | 12,518,000 | $11,239,000 | 0.47% |
| WOLVERINE ASSET MANAGEMENT LLC | 25,780,000 | $23,198,000 | 0.21% |
| AQR Arbitrage LLC | 6,100,000 | $5,522,000 | 0.20% |
| OAKTREE CAPITAL MANAGEMENT LP | 5,350,000 | $4,843,000 | 0.10% |